Print page Resize text Change font-size Change font-size Change font-size


PROTECT News
6 September 2011

PROTECT - NEW journal publications

PROTECT Work Package 2 (Framework for pharmacoepidemiology studies) publishes first results on balancing confounders using propensity score methods and selection of confounding variables for adjustment.

For more information see: PROTECT Publications

6 September 2011

PROTECT at ICPE - abstracts now available online

Several PROTECT researchers presented their results at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management which took place in August in Chicago. The abstracts have been published in Pharmacoepidemiology & Drug Safety.

For more information see:

List of all presentations and

Pharmacoepidemiology & Drug Safety (Volume 20, Issue Supplement S1)

23 May 2011

IMI Stakeholders Forum 2011
IMI held its 2011 Stakeholder Forum on Thursday 12 May in Budapest, Hungary as part of the World of Health IT (WoHIT) eHealth week. Following an invitation by IMI JU the European Medicines Agency represented PROTECT at this event and presented the achievements to date. IMI Executives highlighted PROTECT as a good example of the involvement of regulatory agencies in IMI funded projects.

For more information see: IMI Stakeholders Forum 2011

23 May 2011

IMI JU has approved 1st Project Report
The first periodic report covering the first 12 months of PROTECT (1 September 2009 – 31 August 2010) has been endorsed by the Innovative Medicines Initiative. The report was well received and the consortium was commended on the quality of the report. A summary of the project’s progress made during this period is available on the PROTECT website.

For more information see: Summary of First Periodic Report

12 May 2011

PROTECT External Advisory Board Meeting

The third joint meeting of the PROTECT External Advisory Board and the Steering Committee took place in February 2011. The External Advisory Board reviewed the progress made so far by the individual work packages and provided recommendations for the implementation of the research agenda. It was concluded that the achievements of the project to date were remarkable and the consortium has met the challenge of the project’s considerable scope. The Board also praised the fact that already a number of publications and presentations have emerged or are under preparation. The next joint meeting is scheduled to take place during the first half of 2012.

16 March 2011

Summary of Periodic Report No. 1

The summary of the first Periodic Report is now available online. The report addresses the achievements of the 1st project year, starting on 1 September 2009 and ending on 31 August 2010. The report is a joint effort of the PROTECT Consortium and reflects the progress and main results achieved by the project so far.

For more information see: Summary of First Periodic Report

18 January 2011

New PROTECT Partners

Two new partners have recently joined the PROTECT Consortium. Poznan University of Medical Sciences, a leading Polish medical centre, will mainly contribute to Work Package 4. The second new partner is Takeda Global Research and Development (Europe) Ltd, a research-based global company headquartered in Japan. Takeda will be represented in Work Packages 3 and 5.

For more information see: PROTECT Partners and Work Programme

15 October 2010

PROTECT Consortium Assembly

The 2010 Consortium Assembly took place on 14 October 2010 at the premises of the European Medicines Agency in London. The Assembly reviewed the progress and costs of the project during the first year. An operational and managerial framework as well as the budget for the forthcoming project year were adopted. The final report will be sent to the IMI-JU project office within the next days.

31 August 2010

End of Project Year 1

31 August 2010 marks the end of the first out of five project years for PROTECT. The progress report is currently under preparation, a summary of which will be made publicly available once it has been approved by the Innovative Medicines Initiative (IMI).

14-15 June 2010

IMI Stakeholder Forum

The Innovative Medicines Initiative welcomed industry representatives, regulators, policy makers, scientific experts, patient representatives and science leaders at its first Stakeholder Forum in Brussels. The event featured presentations and discussions about the ongoing IMI projects, the IMI research agenda, the 3rd Call (2010) research topics and the IMI intellectual property policy.

For more information Click here

30 March 2010

PROTECT has signed IMI Grant Agreement

All PROTECT Consortium Partners have successfully acceded to the Grant Agreement which was signed in February between the IMI Joint Undertaking, the European Medicines Agency (PROTECT Project Coordinator) and the Danish Medicines Agency (Managing Entity of PROTECT).
18 May 2009 The Innovative Medicines Initiative (IMI) has announced the names of 15 new research projects, aimed at bringing innovative medicines more quickly to the market, that have been selected to receive €246 million from the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

For more information Click here
For the list of full project proposals Click here

15 May 2009 The first PROTECT Consortium Assembly took place at the offices of the European Medicines Agency (EMEA) in London on 15 May 2009, in preparation for the official start of the project on 1 September 2009.

For photos Click here

29 April 2009 EMEA-coordinated PROTECT project has been accepted for funding by the Innovative Medicines Initiative Joint Undertaking

For the press release Click here